Dual CDK2 and CDK4/6 inhibition suppresses Rb/E2F signaling and enhances anti-leukemic activity in acute myeloid leukemia. - Weisberg E; Chowdhury B; Garg S; Akatsu T; Ni W; Gokhale PC; Eschle BK; Grant S; Sattler M; DeCaprio JA; Nöltner L; Garcia J; et al. (Haematologica, 2026)